The current guidelines, from the U.S. Preventive Services Task Force, say that people ages 50 to 80 who smoked a pack a day ...

Drs Joseph Mikhael and Sigurdur Y. Kristinsson discuss whether it is time to screen for multiple myeloma and what we can ...

While traditional induction therapy for newly diagnosed stage 2 myeloma often focuses on combinations of proteasome inhibitors, immunomodulatory drugs, and steroids, these newer immunotherapy classes ...

Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology ...

Kelly Mann was diagnosed with breast cancer, and later learned that the symptoms she experienced months before were actually triggered by the disease.

Johnson & Johnson (J&J) has received a positive recommendation from the UK’s National Institute for Health and Care ...

Breast cancer is the most common cancer in women, so it's vital to know the signs and symptoms to look out for - and how to ...

We speak to a nurse to find out about the signs and symptoms of breast cancer, plus how to conduct a breast self examination ...

When 59-year-old Betty died from pancreatic cancer, her family were left devastated by how quickly the disease took hold.

Oct 23 (Reuters) - Inhibrx Biosciences (INBX.O), opens new tab said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its ...

The Barbara Ann Karmanos Cancer Institute, along with cancer centers and other organizations nationwide, recognizes November ...

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved treatments, prompting the San Diego biotech to plot a submission to the FDA ...